MLICM
ADMA icon

Metropolitan Life Insurance Company (MetLife)’s ADMA Biologics ADMA Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,618
Closed -$70.1K – 47
2024
Q1 		$70.1K Sell
10,618
-1,685
-14% -$9.21K ﹤0.01% 1242
2023
Q4 		$55.6K Hold
12,303
– – ﹤0.01% 1391
2023
Q3 		$44K Buy
12,303
+938
+8% +$3.61K ﹤0.01% 1479
2023
Q2 		$41.9K Hold
11,365
– – ﹤0.01% 1524
2023
Q1 		$37.6K Sell
11,365
-200
-2% -$691 ﹤0.01% 1544
2022
Q4 		$44.9K Buy
11,565
+4,403
+61% +$13.6K ﹤0.01% 1542
2022
Q3 		$17.4K Sell
7,162
-4,242
-37% -$10.2K ﹤0.01% 2091
2022
Q2 		$22.6K Buy
+11,404
New +$22.4K ﹤0.01% 1991
2020
Q2 		– Sell
-26,075
Closed -$75.1K – 2546
2020
Q1 		$75.1K Buy
+26,075
New +$90.1K ﹤0.01% 2215
2019
Q4 		– Sell
-19,125
Closed -$85.1K – 2536
2019
Q3 		$85.1K Buy
+19,125
New +$79.9K ﹤0.01% 2385

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ADMA Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of ADMA Biologics (ADMA) in Q2 2024, closing a stake of 10,618 shares — an estimated $70.1K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ADMA in Q3 2019 and held it in 10 quarters. The position peaked at $85.1K in Q3 2019. 252 funds tracked by Wall St. Rank hold ADMA as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining ADMA Biologics position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 10,618 ADMA Biologics shares in Q2 2024, an estimated $70.1K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in ADMA Biologics in Q3 2019 and held it in 10 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s ADMA Biologics position peaked at $85.1K in Q3 2019.
  • 252 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.